Page last updated: 2024-11-04

salmeterol xinafoate and Lung Diseases, Obstructive

salmeterol xinafoate has been researched along with Lung Diseases, Obstructive in 2 studies

salmeterol : A racemate consisting of equal parts of (R)- and (S)-salmeterol. It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation.
2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol : A phenol having a hydroxymethyl group at C-2 and a 1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl group at C-4; derivative of phenylethanolamine.

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonnert, RV1
Brown, RC1
Chapman, D1
Cheshire, DR1
Dixon, J1
Ince, F1
Kinchin, EC1
Lyons, AJ1
Davis, AM1
Hallam, C1
Harper, ST1
Unitt, JF1
Dougall, IG1
Jackson, DM1
McKechnie, K1
Young, A1
Simpson, WT1
Jacobsen, JR1
Aggen, JB1
Church, TJ1
Klein, U1
Pfeiffer, JW1
Pulido-Rios, TM1
Thomas, GR1
Yu, C1
Moran, EJ1

Other Studies

2 other studies available for salmeterol xinafoate and Lung Diseases, Obstructive

ArticleYear
Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues.
    Journal of medicinal chemistry, 1998, Dec-03, Volume: 41, Issue:25

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Anti-Asthmatic Agents; Bronc

1998
Multivalent design of long-acting β(2)-adrenoceptor agonists incorporating biarylamines.
    Bioorganic & medicinal chemistry letters, 2014, Jun-15, Volume: 24, Issue:12

    Topics: Adrenergic beta-2 Receptor Agonists; Amines; Animals; Disease Models, Animal; Dose-Response Relation

2014